Metropolitan Life Insurance CO Curis Inc Transaction History

Metropolitan Life Insurance CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.71 - $2.43 $4,343 - $14,864	-6,117 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$2.31 - $5.13 $14,130 - $31,380	6,117 New	6,117 $14,000
Q1 2022 Mar 30, 2023	SELL	$2.31 - $5.13 $42,035 - $93,350	-18,197 Reduced 74.84%	6,117 $14,000
Q1 2022 May 12, 2022	SELL	$2.31 - $5.13 $42,035 - $93,350	-18,197 Reduced 74.84%	6,117 $15,000
Q4 2021 Jun 21, 2023	BUY	$4.45 - $8.09 $108,197 - $196,700	24,314 New	24,314 $115,000
Q4 2021 Mar 30, 2023	BUY	$4.45 - $8.09 $27,487 - $49,971	6,177 Added 34.06%	24,314 $115,000
Q4 2021 Feb 15, 2022	BUY	$4.45 - $8.09 $27,487 - $49,971	6,177 Added 34.06%	24,314 $116,000
Q3 2021 Jun 21, 2023	BUY	$6.94 - $8.85 $125,870 - $160,512	18,137 New	18,137 $142,000
Q3 2021 Mar 30, 2023	SELL	$6.94 - $8.85 $51,390 - $65,534	-7,405 Reduced 28.99%	18,137 $142,000
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $51,390 - $65,534	-7,405 Reduced 28.99%	18,137 $142,000
Q2 2021 Jun 21, 2023	BUY	$7.45 - $16.27 $190,287 - $415,568	25,542 New	25,542 $206,000
Q2 2021 Mar 30, 2023	BUY	$7.45 - $16.27 $190,287 - $415,568	25,542 New	25,542 $206,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $190,287 - $415,568	25,542 New	25,542 $206,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $403M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.